MM

Mezbeen Moiz Momin

Active Director Designated Partner DIN 10222433
DIN 10222433 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mezbeen Moiz Momin

Data last updated:

Mezbeen Moiz Momin is a Designated Partner at Fovero Lifesciences Llp (since 2023). The company operates in Paper.

DIN 10222433
Primary Designation Designated Partner
Industry Paper
First Appointment 03 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Jul 20232023Active

Board colleagues of Mezbeen Moiz Momin

NameDINCompanyDesignation
Hardik Prakash Shah09168740Fovero Lifesciences LlpDesignated Partner
Mayank Sumatiprakash Jain07755797Fovero Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Fovero Lifesciences Llp
Premium access

Shareholding and investment profile for Mezbeen Moiz Momin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mezbeen Moiz Momin

Mezbeen Moiz Momin currently holds 1 directorship: Fovero Lifesciences Llp (Designated Partner, since 03 Jul 2023).

Mezbeen Moiz Momin was first appointed on 03 Jul 2023 as Designated Partner at Fovero Lifesciences Llp.

The current boards of Mezbeen Moiz Momin's companies include Hardik Prakash Shah (Fovero Lifesciences Llp), Mayank Sumatiprakash Jain (Fovero Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available